|
The inactive X: discovering sex genes that influence female vulnerability to Alzheimers disease |
1DP2AG082342-01 |
|
NIA |
2022 |
|
Association of Tau and Neuronal Hypometabolism with Positron Emission Tomography in Alzheimers Disease |
1F30AG074524-01A1 |
|
NIA |
2022 |
|
Aberrant cortical entrainment in biomarker-confirmed Alzheimers disease and mild cognitive impairment |
1F30AG076259-01 |
|
NIA |
2022 |
|
Effects of metabolic phenotype on functional connectivity in aging and Alzheimer’s Disease |
1F30AG076278-01 |
|
NIA |
2022 |
|
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimers Disease |
1F30AG077736-01 |
|
NIA |
2022 |
|
Quantitative Magnetization Transfer Imaging for Early Detection of Alzheimers Disease |
1F30AG077794-01 |
|
NIA |
2022 |
|
Leveraging Clinical Data for Phenotyping and Predictive Modelling of Alzheimer’s Disease |
1F30AG079504-01 |
|
NIA |
2022 |
|
Multimodal, multiclass prediction of disease status in Alzheimer’s |
1F30AG079610-01 |
|
NIA |
2022 |
|
AMPK localization, expression, and activity in Alzheimers Disease |
1F30AG079633-01 |
|
NIA |
2022 |
|
Refining the Use of Polygenic Risk Scores for Alzheimers Disease in Diverse and Founder Populations |
1F31AG072715-01A1 |
|
NIA |
2022 |